Clinical Trial Update: Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the interplay of Par-4 and the telomere-telomerase system in Type 2 diabetes patients. The study involves patients treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonists
• metformin (metformin)

Snippet

Sponsor: Third Military Medical University | Conditions: GLP-1；Metformin；Telomere-telomerase System；Par-4 | Phase 4 | Status: UNKNOWN